89 related articles for article (PubMed ID: 15219643)
1. Growth hormone response to clonidine predicts aggression in Alzheimer's disease.
Herrmann N; Lanctôt KL; Eryavec G; Van Reekum R; Khan LR
Psychoneuroendocrinology; 2004 Oct; 29(9):1192-7. PubMed ID: 15219643
[TBL] [Abstract][Full Text] [Related]
2. Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients.
Herrmann N; Lanctôt KL; Eryavec G; Khan LR
J Psychopharmacol; 2004 Jun; 18(2):215-20. PubMed ID: 15260910
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity of the clonidine and guanfacine tests (alpha-2-adrenergic agonists) as pharmacologic stimulants of growth hormone. Effects on plasma cortisol].
Durá Travé T; Juste Ruiz M; González Montero R; Gutiérrez Terán M; Mauri Dot M; Moya Benavent M
An Esp Pediatr; 1996 Dec; 45(6):575-8. PubMed ID: 9133220
[TBL] [Abstract][Full Text] [Related]
4. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
5. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects.
White HK; McConnell ES; Bales CW; Kuchibhatla M
J Am Med Dir Assoc; 2004; 5(2):89-97. PubMed ID: 14984619
[TBL] [Abstract][Full Text] [Related]
6. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
Coote M; Wilkins A; Werstiuk ES; Steiner M
J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
[TBL] [Abstract][Full Text] [Related]
8. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies.
Gauthier S; Wirth Y; Möbius HJ
Int J Geriatr Psychiatry; 2005 May; 20(5):459-64. PubMed ID: 15852444
[TBL] [Abstract][Full Text] [Related]
9. Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis.
Gauthier S; Loft H; Cummings J
Int J Geriatr Psychiatry; 2008 May; 23(5):537-45. PubMed ID: 18058838
[TBL] [Abstract][Full Text] [Related]
10. Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: a retrospective study.
Caballero J; Hitchcock M; Scharre D; Beversdorf D; Nahata MC
Clin Ther; 2006 Oct; 28(10):1695-700. PubMed ID: 17157125
[TBL] [Abstract][Full Text] [Related]
11. [Behavioral pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): Spanish validation].
Boada M; Tárraga L; Modinos G; Diego S; Reisberg B
Neurologia; 2006; 21(1):19-25. PubMed ID: 16525922
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone and thyrotropin hormone secretion in Alzheimer's disease.
Gomez JM; Aguilar M; Soler J
J Nutr Health Aging; 2000; 4(4):229-32. PubMed ID: 11115806
[TBL] [Abstract][Full Text] [Related]
13. GH response to intravenous clonidine challenge: absence of relationship with behavioral irritability, aggression, or impulsivity in human subjects.
Coccaro EF; Kavoussi RJ
Psychiatry Res; 2010 Jul; 178(2):443-5. PubMed ID: 20483477
[TBL] [Abstract][Full Text] [Related]
14. Effect of long-term estrogen therapy on dopaminergic responsivity in post-menopausal women--a preliminary study.
Craig MC; Cutter WJ; Wickham H; van Amelsvoort TA; Rymer J; Whitehead M; Murphy DG
Psychoneuroendocrinology; 2004 Nov; 29(10):1309-16. PubMed ID: 15288710
[TBL] [Abstract][Full Text] [Related]
15. Limitations of clinical utility of growth hormone stimulating tests in diagnosing children with short stature.
Hilczer M; Smyczynska J; Lewinski A
Endocr Regul; 2006 Sep; 40(3):69-75. PubMed ID: 17100548
[TBL] [Abstract][Full Text] [Related]
16. Age- and gender-related growth hormone responses to intravenous clonidine in healthy adults.
Kimber J; Sivenandan M; Watson L; Mathias CJ
Growth Horm IGF Res; 2001 Apr; 11(2):128-35. PubMed ID: 11472079
[TBL] [Abstract][Full Text] [Related]
17. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
[TBL] [Abstract][Full Text] [Related]
19. Childhood conduct problems, stages of Alzheimer's disease, and physical aggression against caregivers.
O'Leary D; Jyringi D; Sedler M
Int J Geriatr Psychiatry; 2005 May; 20(5):401-5. PubMed ID: 15852459
[TBL] [Abstract][Full Text] [Related]
20. Relationship between behavioural and psychological symptoms of dementia and cognition in Alzheimer's disease.
Starr JM; Lonie J
Dement Geriatr Cogn Disord; 2007; 24(5):343-7. PubMed ID: 17890863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
